Gadolinium-based contrast agents and NSF: evidence from animal experience
- PMID: 19938039
- DOI: 10.1002/jmri.21971
Gadolinium-based contrast agents and NSF: evidence from animal experience
Abstract
Nephrogenic systemic fibrosis (NSF) is a potentially severe systemic disease typically characterized by fibrosis of the skin and connective tissues. The etiology of NSF is still unknown but is likely to be multifactorial. Specific triggers under scientific evaluation have included surgery and/or the occurrence of thrombosis or other vascular injury, proinflammatory state, the administration of high doses of erythropoietin, and more recently the use of gadolinium-based contrast agents (GBCAs). The aim of this review is to summarize knowledge regarding the pathogenesis of NSF and the potential role of GBCAs in its pathology, with a focus on animal experiments. The potential role of complex stability of GCBAs will be highlighted by results from several in vitro and in vivo experiments in rodent models of NSF. J. Magn. Reson. Imaging 2009;30:1268-1276. (c) 2009 Wiley-Liss, Inc.
Similar articles
-
Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?J Magn Reson Imaging. 2009 Dec;30(6):1236-9. doi: 10.1002/jmri.21979. J Magn Reson Imaging. 2009. PMID: 19938035
-
Mechanism of NSF: New evidence challenging the prevailing theory.J Magn Reson Imaging. 2009 Dec;30(6):1277-83. doi: 10.1002/jmri.21980. J Magn Reson Imaging. 2009. PMID: 19937925
-
Nephrogenic systemic fibrosis: clinical spectrum of disease.J Magn Reson Imaging. 2009 Dec;30(6):1289-97. doi: 10.1002/jmri.21975. J Magn Reson Imaging. 2009. PMID: 19937929 Review.
-
Removal of gadolinium by dialysis: review of different strategies and techniques.J Magn Reson Imaging. 2009 Dec;30(6):1347-9. doi: 10.1002/jmri.21981. J Magn Reson Imaging. 2009. PMID: 19937933 Review.
-
Nephrogenic systemic fibrosis.Magn Reson Imaging Clin N Am. 2009 Feb;17(1):159-67. doi: 10.1016/j.mric.2009.01.003. Magn Reson Imaging Clin N Am. 2009. PMID: 19364606 Review.
Cited by
-
Surveillance magnetic resonance imaging for isolated optic pathway gliomas: is gadolinium necessary?Pediatr Radiol. 2018 Sep;48(10):1472-1484. doi: 10.1007/s00247-018-4154-4. Epub 2018 May 22. Pediatr Radiol. 2018. PMID: 29789890
-
Dual-function theranostic nanoparticles for drug delivery and medical imaging contrast: perspectives and challenges for use in lung diseases.Drug Deliv Transl Res. 2013 Aug 1;3(4):352-63. doi: 10.1007/s13346-013-0132-4. Drug Deliv Transl Res. 2013. PMID: 23936754 Free PMC article.
-
Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats.J Magn Reson Imaging. 2018 Mar;47(3):746-752. doi: 10.1002/jmri.25822. Epub 2017 Jul 21. J Magn Reson Imaging. 2018. PMID: 28730643 Free PMC article.
-
Differential effects of two MRI contrast agents on the integrity and distribution of rAAV2 and rAAV5 in the rat striatum.Mol Ther Methods Clin Dev. 2014 Jan 8;1:4. doi: 10.1038/mtm.2013.4. eCollection 2014. Mol Ther Methods Clin Dev. 2014. PMID: 26015943 Free PMC article.
-
Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.Invest Radiol. 2017 Jul;52(7):396-404. doi: 10.1097/RLI.0000000000000352. Invest Radiol. 2017. PMID: 28125438 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical